Zero Candida Commences Trading on OTCQB Market
Zero Candida Technologies (ZCTFF) has announced the commencement of trading on the OTCQB Venture Market under the ticker symbol 'ZCTFF', while maintaining its listings on the TSX Venture Exchange and Frankfurt Stock Exchange.
The OTCQB, operated by OTC Markets Group and recognized by the SEC, serves as a premier market for early-stage and development-stage companies. Listed companies must maintain current financial reporting, meet compliance requirements, and complete annual verification processes.
CEO Eli Ben Haroosh highlighted this milestone as strategic for the company's long-term growth, emphasizing their focus on expanding market presence and partnerships. The listing aligns with their recent patent advancements and aims to capitalize on the growing VVC treatment market, particularly in the U.S.
Zero Candida Technologies (ZCTFF) ha annunciato l'inizio delle negoziazioni sul OTCQB Venture Market con il simbolo di ticker 'ZCTFF', mantenendo al contempo le sue quotazioni sulla TSX Venture Exchange e sulla Borsa di Francoforte.
L'OTCQB, gestito da OTC Markets Group e riconosciuto dalla SEC, funge da mercato di riferimento per le aziende in fase iniziale e di sviluppo. Le aziende quotate devono mantenere una reportistica finanziaria aggiornata, soddisfare i requisiti di conformità e completare i processi di verifica annuale.
Il CEO Eli Ben Haroosh ha sottolineato questo traguardo come strategico per la crescita a lungo termine dell'azienda, enfatizzando il loro focus sull'espansione della presenza sul mercato e delle partnership. La quotazione si allinea con i recenti progressi nei brevetti e mira a capitalizzare il crescente mercato dei trattamenti per la VVC, in particolare negli Stati Uniti.
Zero Candida Technologies (ZCTFF) ha anunciado el inicio de operaciones en el OTCQB Venture Market bajo el símbolo de ticker 'ZCTFF', mientras mantiene sus listados en la TSX Venture Exchange y en la Bolsa de Frankfurt.
El OTCQB, operado por OTC Markets Group y reconocido por la SEC, sirve como un mercado principal para empresas en etapas iniciales y de desarrollo. Las empresas listadas deben mantener informes financieros actualizados, cumplir con los requisitos de conformidad y completar procesos de verificación anual.
El CEO Eli Ben Haroosh destacó este hito como estratégico para el crecimiento a largo plazo de la empresa, enfatizando su enfoque en expandir la presencia en el mercado y las asociaciones. La cotización se alinea con sus recientes avances en patentes y tiene como objetivo capitalizar el creciente mercado de tratamientos para la VVC, especialmente en EE. UU.
제로 칸디다 테크놀로지스 (ZCTFF)는 OTCQB 벤처 마켓에서 'ZCTFF'라는 티커 기호로 거래를 시작한다고 발표했으며, TSX 벤처 거래소 및 프랑크푸르트 증권 거래소에서의 상장도 유지합니다.
OTCQB는 OTC 마켓 그룹이 운영하며 SEC에 의해 인정받은 시장으로, 초기 및 개발 단계 기업을 위한 주요 시장으로 기능합니다. 상장된 기업은 현재 재무 보고서를 유지하고, 준수 요건을 충족하며, 연간 검증 프로세스를 완료해야 합니다.
CEO 엘리 벤 하로쉬는 이 이정표를 회사의 장기 성장에 전략적이라고 강조하며, 시장 존재감과 파트너십 확대에 집중하고 있음을 강조했습니다. 이번 상장은 최근의 특허 발전과 일치하며, 특히 미국에서 성장하는 VVC 치료 시장을 활용하는 것을 목표로 하고 있습니다.
Zero Candida Technologies (ZCTFF) a annoncé le début de la négociation sur le OTCQB Venture Market sous le symbole boursier 'ZCTFF', tout en maintenant ses cotations sur la TSX Venture Exchange et la Bourse de Francfort.
L'OTCQB, géré par OTC Markets Group et reconnu par la SEC, sert de marché de premier plan pour les entreprises en phase de démarrage et de développement. Les entreprises cotées doivent maintenir des rapports financiers à jour, respecter les exigences de conformité et compléter des processus de vérification annuels.
Le PDG Eli Ben Haroosh a souligné ce jalon comme stratégique pour la croissance à long terme de l'entreprise, en mettant l'accent sur leur volonté d'élargir leur présence sur le marché et leurs partenariats. La cotation s'aligne avec leurs récents progrès en matière de brevets et vise à tirer parti du marché en pleine croissance des traitements de VVC, en particulier aux États-Unis.
Zero Candida Technologies (ZCTFF) hat den Beginn des Handels am OTCQB Venture Market unter dem Ticker-Symbol 'ZCTFF' bekannt gegeben und gleichzeitig seine Listings an der TSX Venture Exchange und der Frankfurter Börse beibehalten.
Der OTCQB, betrieben von der OTC Markets Group und von der SEC anerkannt, dient als erstklassiger Markt für Unternehmen in der Früh- und Entwicklungsphase. Gelistete Unternehmen müssen aktuelle Finanzberichte führen, die Compliance-Anforderungen erfüllen und jährliche Verifizierungsprozesse abschließen.
CEO Eli Ben Haroosh hob diesen Meilenstein als strategisch für das langfristige Wachstum des Unternehmens hervor und betonte ihren Fokus auf die Erweiterung der Marktpräsenz und Partnerschaften. Die Listung steht im Einklang mit ihren jüngsten Patentfortschritten und zielt darauf ab, vom wachsenden Markt für VVC-Behandlungen, insbesondere in den USA, zu profitieren.
- Expanded market access through OTCQB listing enhancing stock liquidity
- Multi-exchange presence across North America and Europe
- Recent patent advancements in VVC treatment market
- None.
Eli Ben Haroosh, Founder and CEO of ZCT, commented: "Today's announcement is another exciting milestone for Zero Candida's long-term growth. We look forward to expanding our market presence and strategic partnerships, broadening our investor base to support our mission, and unlock substantial value through AI-driven medical technology. This listing comes at a pivotal time, aligning with our recent patent advancements and the rapidly growing VVC treatment market, driven by strong
For more on this update, watch our latest video:
The OTCQB, operated by the OTC Markets Group and recognized by the
About Zero Candida
Zero Candida (ZCT) is a publicly traded FemTech company pioneering innovative solutions to address unmet needs in women's health. The company is developing a tampon-like device that uses artificial intelligence and therapeutic blue light at a precise wavelength and intensity to effectively treat Candida fungus, with a proven
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Forward-Looking Statements
This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, are forward-looking statements. The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any forward-looking statements, other than as required by law. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Zero Candida. Readers are cautioned not to place undue reliance on forward-looking statements.
Company Contacts:
Victoria Gamble
victoria@zero-candida.com
(647) 874 3767
Eli Ben Haroosh
CEO & Founder
info@zero-candida.com
Logo: https://mma.prnewswire.com/media/2420533/4723164/ZERO_CANDIDA_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/zero-candida-commences-trading-on-otcqb-market-302399761.html
SOURCE Zero Candida
FAQ
What does Zero Candida's OTCQB listing mean for ZCTFF stock trading?
When did ZCTFF stock begin trading on the OTCQB Venture Market?
What markets does Zero Candida (ZCTFF) currently trade on?
What requirements must ZCTFF meet to maintain its OTCQB listing?
